本页面由Tiger Trade Technology Pte. Ltd.提供服务

Castle Biosciences, Inc.

27.91
-0.2600-0.92%
成交量:41.99万
成交额:1,174.77万
市值:8.30亿
市盈率:-33.49
高:28.58
开:27.67
低:27.17
收:28.17
52周最高:44.28
52周最低:14.59
股本:2,973.12万
流通股本:2,511.27万
量比:0.62
换手率:1.67%
股息:- -
股息率:- -
每股收益(TTM):-0.8334
每股收益(LYR):-0.8334
净资产收益率:-5.21%
总资产收益率:-2.56%
市净率:1.76
市盈率(LYR):-33.49

数据加载中...

2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/13

重要事件披露

Form 8-K - Current report
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]